In vitro Characterization of Nanomedicines

One of the causes that increases the time required to reach the market in nanotherapeutics is the preclinical validation. For this to be successful, the nanomaterials needs to be tested under controlled conditions, such as in vitro, prior to start their in vivo testing. This is a crucial step since the standard protocols used for more traditional drugs are not applicable in the case of nanomedicines. NANBIOSIS offers a complete study plan tailored to meet the demands of each nanomedicine product, from the properties of the materials all the way to their preclinical validation. This plan is developed in collaboration with the user and starting from a set of basic analytical tests to more sophisticated experiments.

Description

We offer a complete in vitro Characterization. e.g., immunology, cytotoxicity, hematology, oxidative stress, etc., and more adapted to the different products by using the most sophisticated equipment and taking advantage of the expertise of scientist internationally recognized in the matter.

More info: https://www.nanbiosis.es/in-vitro-characterization-of-nanomedicines/